Related Experiment Videos
[Targeting therapy for renal cancer]
1Dept. of Urology, Akita University School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|May 1, 1994
Summary
Renal cancer is resistant to chemotherapy. Arterial chemoembolization offers a targeted treatment approach by delivering chemotherapy directly to the kidney tumor's blood supply.
Area of Science:
- Oncology
- Interventional Radiology
Context:
- Renal cancer is characterized by resistance to conventional systemic chemotherapy.
- The hypervascular nature of renal tumors presents a unique anatomical target.
- The main artery supplying the renal tumor is accessible for targeted interventions.
Purpose:
- To review the effects of arterial chemoembolization as a targeted chemotherapy approach for renal cancer.
- To evaluate the efficacy and application of transarterial treatments in managing renal tumors.
Summary:
- Renal tumors are typically unresponsive to standard chemotherapy.
- Arterial chemoembolization delivers chemotherapy directly to the tumor via its feeding artery.
- This review examines the outcomes of this targeted treatment modality for renal cancer.
Impact:
- Highlights the potential of transarterial chemoembolization as a treatment for renal cancer.
- Suggests a viable alternative for patients with chemotherapy-resistant renal tumors.
- Emphasizes the importance of anatomical targeting in cancer therapy.